An Immunomics Approach to Schistosome Antigen Discovery: Antibody Signatures of Naturally Resistant and Chronically Infected Individuals from Endemic Areas

PLoS Pathogens

Volumn 10, Issue 3, 2014, Pages

  Gaze, Soraya ^a,b   Driguez, Patrick ^c   Pearson, Mark S ^a   Mendes, Tiago ^d   Doolan, Denise L ^c   Trieu, Angela ^c   McManus, Donald P ^c   Gobert, Geoffrey N ^c   Periago, Maria Victoria ^b   Correa Oliveira, Rodrigo ^b   Cardoso, Fernanda C ^c,e   Oliveira, Guilherme ^b   Nakajima, Rie ^f   Jasinskas, Al ^f   Hung, Chris ^f   Liang, Li ^f   Pablo, Jozelyn ^f   Bethony, Jeffrey M ^g   Felgner, Philip L ^f   Loukas, Alex ^a  

^a JAMES COOK UNIVERSITY   (Australia)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^d FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^e UNIVERSITY OF QUEENSLAND   (Australia)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; PARASITE ANTIGEN; SCHISTOSOME ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; FECES ANALYSIS; HOMOLOGOUS RECOMBINATION; HUMAN; IMMUNE RESPONSE; IMMUNOREACTIVITY; INFECTION; LONGITUDINAL STUDY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN MICROARRAY; QUALITY CONTROL; SCHISTOSOMIASIS; UNINDEXED SEQUENCE;

ADOLESCENT; ADULT; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; BRAZIL; CHRONIC DISEASE; CLUSTER ANALYSIS; DISEASE RESISTANCE; ENDEMIC DISEASES; FEMALE; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; MALE; MIDDLE AGED; NEGLECTED DISEASES; PROTEIN ARRAY ANALYSIS; SCHISTOSOMIASIS; VACCINES; YOUNG ADULT;

EID: 84897465663     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004033     Document Type: Article

References (81)

1. van der Werf MJ, de Vlas SJ, Brooker S, Looman CWN, Nagelkerke NJD, et al. (2003) Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop 86: 125-139.
2. King CH, Dickman K, Tisch DJ, (2005) Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet 365: 1561-1569.
3. King CH, Dangerfield-Cha M, (2008) The unacknowledged impact of chronic schistosomiasis. Chronic Illn 4: 65-79.
4. Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J, (2006) Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis 6: 411-425.
5. Gray DJ, McManus DP, Li Y, Williams GM, Bergquist R, et al. (2010) Schistosomiasis elimination: lessons from the past guide the future. Lancet Infect Dis 10: 733-736.
6. Fallon PG, Doenhoff MJ, (1994) Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific. Am J Trop Med Hyg 51: 83-88.
7. Wang W, Wang L, Liang Y-S, (2012) Susceptibility or resistance of praziquantel in human schistosomiasis: a review. Parasitol Res 111: 1871-1877.
8. Fenwick A, (2006) Waterborne infectious diseases-could they be consigned to history? Science 313: 1077-1081.
9. Clements ACA, Bosqué-Oliva E, Sacko M, Landouré A, Dembélé R, et al. (2009) A comparative study of the spatial distribution of schistosomiasis in Mali in 1984-1989 and 2004-2006. PLoS Negl Trop Dis 3: e431.
10. Woolhouse ME, (1998) Patterns in parasite epidemiology: the peak shift. Parasitol Today 14: 428-434.
11. Black CL, Mwinzi PNM, Muok EMO, Abudho B, Fitzsimmons CM, et al. (2010) Influence of exposure history on the immunology and development of resistance to human Schistosomiasis mansoni. PLoS Negl Trop Dis 4: e637.
12. Skelly PJ, Alan Wilson R, (2006) Making sense of the schistosome surface. Adv Parasitol 63: 185-284.
13. Nuttall PA, Trimnell AR, Kazimirova M, Labuda M, (2006) Exposed and concealed antigens as vaccine targets for controlling ticks and tick-borne diseases. Parasite Immunol 28: 155-163.
14. Knox DP, (2000) Development of vaccines against gastrointestinal nematodes. Parasitology 120Suppl: S43-S61.
15. Johnson KS, Harrison GB, Lightowlers MW, O'Hoy KL, Cougle WG, et al. (1989) Vaccination against ovine cysticercosis using a defined recombinant antigen. Nature 338: 585-587.
16. Lightowlers MW, Lawrence SB, Gauci CG, Young J, Ralston MJ, et al. (1996) Vaccination against hydatidosis using a defined recombinant antigen. Parasite Immunol 18: 457-462.
17. Riveau G, Deplanque D, Remoué F, Schacht A-M, Vodougnon H, et al. (2012) Safety and immunogenicity of rSh28GST antigen in humans: phase 1 randomized clinical study of a vaccine candidate against urinary schistosomiasis. PLoS Negl Trop Dis 6: e1704.
18. Tendler M, Simpson AJG, (2008) The biotechnology-value chain: development of Sm14 as a schistosomiasis vaccine. Acta Trop 108: 263-266.
19. Hotez PJ, Bethony JM, Diemert DJ, Pearson M, Loukas A, (2010) Developing vaccines to combat hookworm infection and intestinal schistosomiasis. Nature Rev Microbiol 8: 814-826.
20. McManus DP, Loukas A, (2008) Current status of vaccines for schistosomiasis. Clin Microbiol Rev 21: 225-242.
21. Loukas A, Gaze S, Mulvenna JP, Gasser RB, Brindley PJ, et al. (2011) Vaccinomics for the major blood feeding helminths of humans. OMICS 15: 567-577.
22. Martins VP, Pinheiro CS, Figueiredo BCP, Assis NRG, Morais SB, et al. (2012) Vaccination with enzymatically cleaved GPI-anchored proteins from Schistosoma mansoni induces protection against challenge infection. Clin Dev Immunol 2012: 962538.
23. Castro-Borges W, Dowle A, Curwen RS, Thomas-Oates J, Wilson RA, (2011) Enzymatic shaving of the tegument surface of live schistosomes for proteomic analysis: a rational approach to select vaccine candidates. PLoS Negl Trop Dis 5: e993.
24. Cardoso FC, Macedo GC, Gava E, Kitten GT, Mati VL, et al. (2008) Schistosoma mansoni tegument protein Sm29 is able to induce a Th1-type of immune response and protection against parasite infection. PLoS Negl Trop Dis 2: e308.
25. Ahmad G, Zhang W, Torben W, Ahrorov A, Damian RT, et al. (2011) Preclinical prophylactic efficacy testing of Sm-p80-based vaccine in a nonhuman primate model of Schistosoma mansoni infection and immunoglobulin G and E responses to Sm-p80 in human serum samples from an area where schistosomiasis is endemic. J Infect Dis 204: 1437-1449.
26. Tran MH, Pearson MS, Bethony JM, Smyth DJ, Jones MK, et al. (2006) Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis. Nature Med 12: 835-840.
27. Young ND, Jex AR, Li B, Liu S, Yang L, et al. (2012) Whole-genome sequence of Schistosoma haematobium. Nature Genet 44: 221-225.
28. Schistosoma japonicum Genome Sequencing and Functional Analysis Consortium (2009) The Schistosoma japonicum genome reveals features of host-parasite interplay. Nature 460: 345-351.
29. Berriman M, Haas BJ, LoVerde PT, Wilson RA, Dillon GP, et al. (2009) The genome of the blood fluke Schistosoma mansoni. Nature 460: 352-358.
30. Braschi S, Wilson RA, (2006) Proteins exposed at the adult schistosome surface revealed by biotinylation. Mol Cell Proteomics 5: 347-356.
31. Mulvenna J, Moertel L, Jones MK, Nawaratna S, Lovas EM, et al. (2010) Exposed proteins of the Schistosoma japonicum tegument. Int J Parasitol 40: 543-554.
32. Gazzinelli A, Bethony J, Fraga LA, LoVerde PT, Correa-Oliveira R, et al. (2001) Exposure to Schistosoma mansoni infection in a rural area of Brazil. I: water contact. Trop Med Int Health 6: 126-135.
33. Bethony J, Williams JT, Kloos H, Blangero J, Alves-Fraga L, et al. (2001) Exposure to Schistosoma mansoni infection in a rural area in Brazil. II: household risk factors. Trop Med Int Health 6: 136-145.
34. Bethony J, Williams JT, Brooker S, Gazzinelli A, Gazzinelli MF, et al. (2004) Exposure to Schistosoma mansoni infection in a rural area in Brazil. Part III: household aggregation of water-contact behaviour. Trop Med Int Health 9: 381-389.
35. Viana IR, Sher A, Carvalho OS, Massara CL, Eloi-Santos SM, et al. (1994) Interferon-gamma production by peripheral blood mononuclear cells from residents of an area endemic for Schistosoma mansoni. Trans R Soc Trop Med Hyg 88: 466-470.
36. Caldas IR, Correa-Oliveira R, Colosimo E, Carvalho OS, Massara CL, et al. (2000) Susceptibility and resistance to Schistosoma mansoni reinfection: parallel cellular and isotypic immunologic assessment. Am J Trop Med Hyg 62: 57-64.
37. Bahia-Oliveira LM, Simpson AJ, Alves-Oliveira LF, Carvalho-Queiroz C, Silveira AM, et al. (1996) Evidence that cellular immune responses to soluble and membrane associated antigens are independently regulated during human schistosomiasis mansoni. Parasite Immunol 18: 53-63.
38. Driguez P, Doolan DL, Loukas A, Felgner PL, McManus DP, (2010) Schistosomiasis vaccine discovery using immunomics. Parasit Vectors 3: 4.
39. Diemert DJ, Pinto AG, Freire J, Jariwala A, Santiago H, et al. (2012) Generalized urticaria induced by the Na-ASP-2 hookworm vaccine: implications for the development of vaccines against helminths. J Allergy Clin Immunol 130: 169-76.e6.
40. Hartigan JA, Wong MA, (1979) Algorithm AS 136: a k-means clustering algorithm. J Royal Stat Soc Series C (Appl Stats) 28: 100-108.
41. Defays D, (1977) An efficient algorithm for a complete link method. The Computer Journal 20: 364-366.
42. De Groot AS, (2009) Exploring the immunome: A brave new world for human vaccine development. Hum Vaccin 5: 790-793.
43. Vigil A, Davies DH, Felgner PL, (2010) Defining the humoral immune response to infectious agents using high-density protein microarrays. Future Microbiol 5: 241-251.
44. Davies DH, Molina DM, Wrammert J, Miller J, Hirst S, et al. (2007) Proteome-wide analysis of the serological response to vaccinia and smallpox. Proteomics 7: 1678-1686.
45. Harrop R, Jennings N, Mountford AP, Coulson PS, Wilson RA, (2000) Characterization, cloning and immunogenicity of antigens released by transforming cercariae of Schistosoma mansoni. Parasitology 121: 385-394.
46. Moloney NA, Webbe G, (1990) Antibody is responsible for the passive transfer of immunity to mice from rabbits, rats or mice vaccinated with attenuated Schistosoma japonicum cercariae. Parasitology 100: 235-239.
47. Cioli D, Blum K, Ruppel A, (1978) Schistosoma mansoni: relationship between parasite age and time of spontaneous elimination from the rat. Exp Parasitol 45: 74-80.
48. Cêtre C, Pierrot C, Cocude C, Lafitte S, Capron A, et al. (1999) Profiles of Th1 and Th2 cytokines after primary and secondary infection by Schistosoma mansoni in the semipermissive rat host. Infect Immun 67: 2713-2719.
49. Barker RH, Srivastava BS, Suri P, Goldberg M, Knopf PM, (1985) Immunoprecipitation analysis of radiolabelled protein antigens biosynthesized in vitro by S. mansoni. I. Identification of antigens uniquely recognized by protective antibodies. J Immunol 134: 1192-1201.
50. Sepulveda J, Tremblay JM, DeGnore JP, Skelly PJ, Shoemaker CB, (2010) Schistosoma mansoni host-exposed surface antigens characterized by sera and recombinant antibodies from schistosomiasis-resistant rats. Int J Parasitol 40: 1407-1417.
51. Doenhoff MJ, Sabah AA, Fletcher C, Webbe G, Bain J, (1987) Evidence for an immune-dependent action of praziquantel on Schistosoma mansoni in mice. Trans R Soc Trop Med Hyg 81: 947-951.
52. Brindley PJ, Sher A, (1987) The chemotherapeutic effect of praziquantel against Schistosoma mansoni is dependent on host antibody response. J Immunol 139: 215-220.
53. Walter K, Fulford AJC, McBeath R, Joseph S, Jones FM, et al. (2006) Increased human IgE induced by killing Schistosoma mansoni in vivo is associated with pretreatment Th2 cytokine responsiveness to worm antigens. J Immunol 177: 5490-5498.
54. Joseph S, Jones FM, Walter K, Fulford AJ, Kimani G, et al. (2004) Increases in human T helper 2 cytokine responses to Schistosoma mansoni worm and worm-tegument antigens are induced by treatment with praziquantel. J Infect Dis 190: 835-842.
55. Hagan P, Blumenthal UJ, Dunn D, Simpson AJ, Wilkins HA, (1991) Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium. Nature 349: 243-245.
56. Bahia-Oliveira LM, Gazzinelli G, Eloi-Santos SM, Cunha-Melo JR, Alves-Oliveira LF, et al. (1992) Differential cellular reactivity to adult worm antigens of patients with different clinical forms of schistosomiasis mansoni. Trans R Soc Trop Med Hyg 86: 57-61.
57. Corrêa-Oliveira R, Caldas IR, Gazzinelli G, (2000) Natural versus drug-induced resistance in Schistosoma mansoni infection. Parasitol Today 16: 397-399.
58. Viana IR, Correa-Oliveira R, Carvalho ODS, Massara CL, Colosimo E, et al. (1995) Comparison of antibody isotype responses to Schistosoma mansoni antigens by infected and putative resistant individuals living in an endemic area. Parasite Immunol 17: 297-304.
59. Bethony JM, Simon G, Diemert DJ, Parenti D, Desrosiers A, et al. (2008) Randomized, placebo-controlled, double-blind trial of the Na-ASP-2 hookworm vaccine in unexposed adults. Vaccine 26: 2408-2417.
60. Gobert GN, Moertel L, Brindley PJ, McManus DP, (2009) Developmental gene expression profiles of the human pathogen Schistosoma japonicum. BMC Genomics 10: 128.
61. Gobert GN, Tran MH, Moertel L, Mulvenna J, Jones MK, et al. (2010) Transcriptional changes in Schistosoma mansoni during early schistosomula development and in the presence of erythrocytes. PLoS Negl Trop Dis 4: e600.
62. You H, McManus DP, Hu W, Smout MJ, Brindley PJ, et al. (2013) Transcriptional responses of in vivo praziquantel exposure in schistosomes identifies a functional role for calcium signalling pathway member CamKII. PLoS Pathog 9: e1003254.
63. van Balkom BWM, van Gestel RA, Brouwers JFHM, Krijgsveld J, Tielens AGM, et al. (2005) Mass spectrometric analysis of the Schistosoma mansoni tegumental sub-proteome. J Proteome Res 4: 958-966.
64. Taft AS, Yoshino TP, (2011) Cloning and functional characterization of two calmodulin genes during larval development in the parasitic flatworm Schistosoma mansoni. J Parasitol 97: 72-81.
65. Katsumata T, Kohno S, Yamaguchi K, Hara K, Aoki Y, (1989) Hatching of Schistosoma mansoni eggs is a Ca2+/calmodulin-dependent process. Parasitol Res 76: 90-91.
66. Geary TG, Divo AA, Jensen JB, (1986) Effect of calmodulin inhibitors on viability and mitochondrial potential of Plasmodium falciparum in culture. Antimicrob Agents Chemother 30: 785-788.
67. Pearson MS, Pickering DA, McSorley HJ, Bethony JM, Tribolet L, et al. (2012) Enhanced protective efficacy of a chimeric form of the schistosomiasis vaccine antigen Sm-TSP-2. PLoS Negl Trop Dis 6: e1564.
68. Doolan DL, Mu Y, Unal B, Sundaresh S, Hirst S, et al. (2008) Profiling humoral immune responses to P. falciparum infection with protein microarrays. Proteomics 8: 4680-4694.
69. Crompton PD, Kayala MA, Traore B, Kayentao K, Ongoiba A, et al. (2010) A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray. Proc Natl Acad Sci U S A 107: 6958-6963.
70. Barry AE, Trieu A, Fowkes FJI, Pablo J, Kalantari-Dehaghi M, et al. (2011) The stability and complexity of antibody responses to the major surface antigen of Plasmodium falciparum are associated with age in a malaria endemic area. Mol Cell Proteomics 10: M111.008326.
71. Trieu A, Kayala MA, Burk C, Molina DM, Freilich DA, et al. (2011) Sterile protective immunity to malaria is associated with a panel of novel P. falciparum antigens. Mol Cell Proteomics 10: M111.007948.
72. Mutapi F, Burchmore R, Mduluza T, Foucher A, Harcus Y, et al. (2005) Praziquantel treatment of individuals exposed to Schistosoma haematobium enhances serological recognition of defined parasite antigens. J Infect Dis 192: 1108-1118.
73. Marcilla A, Trelis M, Cortés A, Sotillo J, Cantalapiedra F, et al. (2012) Extracellular vesicles from parasitic helminths contain specific excretory/secretory proteins and are internalized in intestinal host cells. PLoS One 7: e45974.
74. Kariuki TM, Van Dam GJ, Deelder AM, Farah IO, Yole DS, et al. (2006) Previous or ongoing schistosome infections do not compromise the efficacy of the attenuated cercaria vaccine. Infect Immun 74: 3979-3986.
75. Yole DS, Pemberton R, Reid GD, Wilson RA, (1996) Protective immunity to Schistosoma mansoni induced in the olive baboon Papio anubis by the irradiated cercaria vaccine. Parasitology 112: 37-46.
76. Rollinson D, (2009) A wake up call for urinary schistosomiasis: reconciling research effort with public health importance. Parasitology 136: 1593-1610.
77. Davies DH, Liang X, Hernandez JE, Randall A, Hirst S, et al. (2005) Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery. Proc Natl Acad Sci U S A 102: 547-552.
78. Sundaresh S, Doolan DL, Hirst S, Mu Y, Unal B, et al. (2006) Identification of humoral immune responses in protein microarrays using DNA microarray data analysis techniques. Bioinformatics 22: 1760-1766.
79. Brock G, Pihur V, Datta S, Datta S (2008) clValid, an R package for cluster validation. J Stat Software 25(4).
80. RDC Team (2011) R: a language and environment for statistical computing, reference index version 2.13.0. Vienna: R Foundation for Statistical Computing.
81. Protasio AV, Tsai IJ, Babbage A, Nichol S, Hunt M, et al. (2012) A systematically improved high quality genome and transcriptome of the human blood fluke Schistosoma mansoni. PLoS Negl Trop Dis 6: e1455.